INS and diabetes mellitus: Adjusting for age, baseline HbA1c, sex, the duration of diabetes, and baseline premixed insulin dose, patients in the LCCP group had 0.492% (P=.002) more HbA1c reduction relative to baseline than the non-LCCP group (see Table 3).